Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haploidentical Stem Cell Transplantation Utilizing Purified CD34+ Hematopoietic Cells for Patients With Hematologic Malignancies

NCT00186823 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.

NCT NCT00186823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00186823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haploidentical Stem Cell Transplantation Utilizing Purified CD34+ Hematopoietic Cells for Patients With Hematologic Malignancies
Lead sponsor
St. Jude Children's Research Hospital
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2002
Completion date
January 31, 2009
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemoglobinuria, paroxysmal nocturnal (pnh), juvenile myelomonocytic leukemia(jmml), leukemia, acute lymphocytic (all), leukemia, myeloid, acute(aml), leukemia, myeloid, chronic(cml), lymphoma, non-hodgkin (nhl), myelodysplastic syndrome (mds)